Author

R. S. Peebles

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:metabolism & bioenergetics· 1

Frequent Co-Authors

A. Garg· 1 shared A. I. Sperling· 1 shared A. L. Raybuck· 1 shared A. M. Eddie· 1 shared A. Silva Pena· 1 shared A. Sugiura· 1 shared C. C. Stobart· 1 shared C. Chi· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 13 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Garg

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Androgen Signaling Restricts Glutaminolysis to Drive Sex-Specific Th17 Metabolism

N. U. Chowdhury, J.-Y. Cephus, M. Z. Madden, M. M. Wolf, C. Chi, A. Sugiura, M. T. Stier, K. Voss, X. Ye, S. N. Kuehnle, K. Scales, V. D. Gandhi, R. D. Guzy, K. N. Cahill, A. I. Sperling, , D. C. Newcomb

The paper shows that androgen signaling reduces glutaminolysis in male Th17 cells, leading to sex-specific metabolic differences that affect Th17-mediated inflammation.

bioRxiv · Feb 10, 2023 · PreprintImmunology

Selective pharmaceutical inhibition of PARP14 mitigates allergen-induced IgE and mucus overproduction in a mouse model of pulmonary allergic response

A. M. Eddie, L. B. Schenkel, K. K. Swinger, J. R. Molina, K. Kunii, A. L. Raybuck, H. Keilhack, M. Niepel, R. S. Peebles, M. R. Boothby, S. H. Cho

This study shows that inhibiting PARP14's catalytic activity reduces allergen-induced IgE and mucus overproduction in a mouse model of allergic response.

ImmunoHorizons · Jul 1, 2022Peer-reviewedImmunology

One mucosal administration of a live attenuated recombinant COVID-19 vaccine protects non-human primates from SARS-CoV-2

M. F. Tioni, R. Jordan, A. Silva Pena, A. Garg, D. Wu, S. I. Phan, X. Cheng, J. Greenhouse, T. Orekov, D. Valentin, S. Kar, L. Pessaint, H. Andersen, C. C. Stobart, M. H. Bloodworth, , R. S. Tang

This study shows that a single mucosal dose of the live attenuated RSV-based vaccine MV-014-212 protects non-human primates from SARS-CoV-2 infection by reducing viral shedding and inducing neutralizing antibodies.

bioRxiv · Jul 16, 2021Immunology